Vanderbilt Ingram Cancer Center Archive — Page 17 of 48
-
February 5, 2020
Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report
Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer. -
February 5, 2020
Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform
Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform. -
January 29, 2020
Protein research seeks to induce tumor regression
Understanding how MYC interacts with WDR5 and other cofactors could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks. -
January 16, 2020
Journey Home Project supports first CAR-T infusion at VA hospital
The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville. -
January 9, 2020
Park named interim Hematology and Oncology director
Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology. -
December 12, 2019
Richmond receives legacy award from Society for Leukocyte Biology
Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award. -
December 5, 2019
Balko lands Mary Kay Foundation grant for breast cancer research
Vanderbilt-Ingram Cancer Center's Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.